 10 years in patients with
peripheral arterial-disease. N Engl J Med 1992;326:381-6.
6. McDermott MM, Feinglass J, Slavensky R, Pearce WH. The anklebrachial index as a predictor of survival in patients with peripheral
arterial disease. J Gen Intern Med 1994;9:445-9.
7. McGrath MA, Graham AR, Hill DA, Lord RSA, Tracy GD. The
natural history of chronic leg ischemia. World J Surg 1983;7:314-8.
8. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S,
et al. Recommended standards for reports dealing with lower extremity
ischemia: revised version. J Vasc Surg 1997;26:517-38.
9. Dormandy JA, Rutherford RB. Management of peripheral arterial
disease (PAD). TASC Working Group: TransAtlantic Inter-Society
Consensus (TASC). J Vasc Surg 2000;31(Suppl):S1-296.
10. Setacci C, Ricco JB, Apelqvist J, Becker F, Cao P. Management of
critical limb ischemia and diabetic foot. Eur J Vas Endovas Surg
2011;42(S2):S1-90.
11. Brass EP, Anthony R, Dormandy J, Hiatt WR, Jiao J, Nakanishi A,
et al. Parenteral therapy with lipo-ecraprost, a lipid-based formulation
of a PGE1 analog, does not alter six-month outcomes in patients with
critical leg ischemia. J Vasc Surg 2006;43:752-9.
12. Marston WA, Davies SW, Armstrong B, Farber MA, Mendes RC,
Fulton JJ, et al. Natural history of limbs with arterial insufﬁciency and
chronic ulceration treated without revascularization. J Vasc Surg
2006;44:108-14.
13. Elgzyri T, Larsson J, Thörne J, Eriksson KF, Ap